In a recent randomized, placebo-controlled trial in 50 subjects with recent onset of schizophrenia who were medicated, daily supplementation with EPA (740 mg) and DHA (400 mg) reduced psychotic symptoms (assessed with the Brief Psychiatric Rating Scale) only in those who were not taking the anxiolytic, lorazepam (Ativan) (200)
In preclinical studies, BPC-157 has shown to have a positive impact when treating conditions such as inflammatory bowel disease, traumatic brain injury, and arthritis [5]
While not directly targeting GLP-1 pathways as extensively as Akkermansia or butyrate-producers, these strains serve important ecosystem support functions
Customizable Treatment for Your Skins Needs: One of the best things about IV Drip therapy is that it can be tailored to your specific needs
The recent surge in interest in GLP-1 medications has led to a growing market for supplements
For those with good coverage, the program can feel both supportive and affordable